首页 | 本学科首页   官方微博 | 高级检索  
     

凯时治疗慢性重症肝炎25例临床观察
引用本文:王建玲. 凯时治疗慢性重症肝炎25例临床观察[J]. 现代中西医结合杂志, 2002, 11(5): 397-398
作者姓名:王建玲
作者单位:广西南宁市第四人民医院内一科,530023
摘    要:目的 :观察凯时即前列地尔脂微球载体制剂 (L ipo-PGE1 )治疗慢性重症肝炎的疗效。方法 :将 5 0例慢性重症肝炎患者随机分成两组 ,对照组予综合治疗及对症治疗 ,治疗组在该基础上加用 Lipo-PGE1 治疗。结果 :治疗组在改善临床症状及肝功能方面疗效显著 ,明显高于对照组 (P<0 .0 1)。结论 :Lipo-PGE1 是一种治疗慢性重症肝炎高效、安全的药物

关 键 词:慢性  重症肝炎  Lipo-PGE1

Clinical observation of Lipo-PGE1 on 25 patients with chronic serious hepatitis
Wang Jianling Internal Medicine Department,the Forth People's Hospital of Nanning,Nanning ,Guangxi,China. Clinical observation of Lipo-PGE1 on 25 patients with chronic serious hepatitis[J]. Modern Journal of Integrated Chinese Traditional and Western Medicine, 2002, 11(5): 397-398
Authors:Wang Jianling Internal Medicine Department  the Forth People's Hospital of Nanning  Nanning   Guangxi  China
Affiliation:Wang Jianling Internal Medicine Department,the Forth People's Hospital of Nanning,Nanning 530023,Guangxi,China
Abstract:Objective:It is to observe the effect of Lipo PGE 1 on chronic serious hepatitis. Methods: Fifty patients with chronic serious hepatitis were divided into two groups randomly. The control group was treated with traditional complex. The treatment group was treated with traditional complex and Lipo PGE 1. Results: The effects of treatment group on improving patients' clinical symptoms and liver function were higher than those of control group ( P <0.01). Conclusion:Lipo PGE 1 is a highly efficacy and safe medicine for treating chronic serious hepatitis.
Keywords:chronic serious hepatitis Lipo PGE 1
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号